What is a summary of adverse transfusion reactions, including their types, clinical presentation, and management?

Adverse Transfusion Reactions Summary

Transfusion-associated circulatory overload (TACO) is now the leading cause of transfusion-related mortality and major morbidity, requiring heightened vigilance in high-risk patients including those over 70 years, with heart or renal failure, low body weight, or receiving rapid transfusions 1.

Major Categories of Transfusion Reactions

Life-Threatening Reactions

Pulmonary Complications (TACO, TRALI, Transfusion-Associated Dyspnea)

• These account for 65% of transfusion-related fatalities despite representing only 35% of serious reactions 2
• TACO presents with acute respiratory compromise, pulmonary edema, tachycardia, and hypertension within 12 hours of transfusion 1
• TRALI occurs at a rate of 8.1 per 100,000 transfused components 3
• Monitor respiratory rate continuously—dyspnea and tachypnea are the earliest warning signs 1

Hemolytic Reactions

• Fatal hemolysis occurs at approximately 8 per 10 million RBC units transfused 3
• Risk is 1:1,250,000 transfusions based on FDA data from 2005-2010 3
• Prevented primarily through rigorous patient identification and cross-matching

Septic Transfusion Reactions

• Rare but serious complications currently targeted for reduction 4
• Life-threatening reactions requiring major intervention (vasopressors, intubation, ICU transfer) occur in 1:139,908 transfusions 3

Common Non-Life-Threatening Reactions

Febrile Non-Hemolytic Reactions

• Occur in 1.1-2.15% of transfusions depending on leukoreduction timing 3
• More commonly associated with RBC units 1
• Manage with intravenous paracetamol only—avoid indiscriminate steroid use 1

Allergic Reactions

• Most frequent reaction type (41% of all adverse reactions) 2
• More commonly associated with plasma and platelet products 1
• Treat with antihistamines only for mild-moderate reactions; follow anaphylaxis protocols for severe reactions 1

Alloimmunization

• Among the most frequent transfusion reactions reported 5

Infectious Complications

Viral Transmission (Extremely Rare)

• HIV: 6.8 per 10 million components (1:1,467,000) 3
• HCV: 8.7 per 10 million components (1:1,149,000) 3
• HBV: 2.8-3.6 per 10 million components 3
• Hepatitis incidence significantly decreased with nucleic acid amplification testing 4

Transfusion-Associated GVHD

• No cases reported in over 20 years where irradiated blood is used 4

Essential Monitoring Protocol

Mandatory Observation Schedule 1:

• Before transfusion (within 60 minutes)
• 15 minutes after starting each unit
• Within 60 minutes of completing transfusion
• Monitor: respiratory rate, pulse, blood pressure, temperature

Risk Mitigation for TACO (Highest Priority)

For patients >70 years, heart failure, renal failure, hypoalbuminemia, or low body weight 1:

• Critically assess transfusion necessity
• Use body weight-based RBC dosing
• Transfuse slowly
• Monitor vital signs and fluid balance closely
• Consider prophylactic diuretics

Management Algorithm for Any Suspected Reaction

1. Stop the transfusion immediately 5, 6
2. Report to blood bank/hemovigilance system 5, 6
3. Distinguish reaction type based on symptoms:
   • Fever alone → IV paracetamol 1
   • Urticaria/pruritus → Antihistamine 1
   • Respiratory symptoms → Consider TACO/TRALI, consult ICU 5
   • Severe/anaphylaxis → Follow local anaphylaxis protocol 1
4. Maintain IV access with normal saline
5. Early hematology and ICU consultation for serious reactions 5

Critical Pitfalls to Avoid

• Do not use steroids and antihistamines indiscriminately—this may further immunosuppress vulnerable patients 1
• Do not dismiss respiratory symptoms—they signal the most lethal complications 1
• Any symptom within 24 hours of transfusion should be considered a transfusion reaction 5
• Overall adverse reaction risk is 1 in 455 components transfused, but serious reactions occur in 1 in 6,224 2